Ignite Creation Date:
2025-12-25 @ 3:47 AM
Ignite Modification Date:
2025-12-26 @ 2:34 AM
Study NCT ID:
NCT06034002
Status:
RECRUITING
Last Update Posted:
2025-10-30
First Post:
2023-08-30
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms
Sponsor:
Incyte Corporation
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-12-04
Start Date Type:
ACTUAL
Primary Completion Date:
2028-10-29
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-10-29
Completion Date Type:
ESTIMATED
First Submit Date:
2023-08-30
First Submit QC Date:
None
Study First Post Date:
2023-09-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-10-28
Last Update Post Date:
2025-10-30
Last Update Post Date Type:
ESTIMATED